DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Balan V, Nelson DR, Sulkowski MS. et al.
Phase I/II study evaluating escalating subcutaneous doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy
Antivir Ther 2006; 11: 35-45
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.